Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Cited by (1,005)

Items 201–300 of 1,005

1. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease
   Michael D. Ezekowitz, Rangadham Nagarakanti, Herbert Noack, Martina Brueckmann, Claire Litherland, Mark Jacobs, Andreas Clemens, Paul A. Reilly, Stuart J. Connolly, Salim Yusuf et al. · 2016 · Circulation
2. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation
   Victoria Jacobs, Heidi Thomas May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler, John D. Day, Charles D. Mallender, Jeffrey S. Osborn, Scott M. Stevens, J. Peter Weiss et al. · 2016 · The American Journal of Cardiology
3. Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation
   Judith S. Hecker, Sandra Marten, Loretta Keller, Sindy Helmert, Franziska Michalski, Sebastian Werth, Kurtuluş Şahin, Luise Tittl, Jan Beyer‐Westendorf · 2016 · Thrombosis and Haemostasis
4. Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice
   Xiaoyan Li, Steve Deitelzweig, Allison V. Keshishian, Melissa Hamilton, Ruslan V. Horblyuk, Kiran B. Gupta, Xuemei Luo, Jack Mardekian, Keith E. Friend, Anagha Nadkarni et al. · 2017 · Thrombosis and Haemostasis
5. Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants
   Sophie Testa, Oriana Paoletti, Cristina Legnani, Claudia Dellanoce, Emilia Antonucci, Benilde Cosmi, Vittorio Pengo, D. Poli, Rossella Morandini, Roberto Testa et al. · 2018 · Journal of Thrombosis and Haemostasis
6. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
   Di Biase, Luigi, Lakkireddy, Dhanujaya, Trivedi, Chintan, Deneke, Thomas, Martinek, Martin, Mohanty, Sanghamitra, Mohanty, Prasant, Prakash, Sameer, Bai, Rong, Reddy, Madhu et al. · 2015 · Heart Rhythm
7. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
   Essien, Utibe R., Holmes, DaJuanicia N., Jackson, Larry R., Fonarow, Gregg C., Mahaffey, Kenneth W., Reiffel, James A., Steinberg, Benjamin A., Allen, Larry A., Chan, Paul S., Freeman, James V. et al. · 2018 · JAMA Cardiology
8. Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
   Christina L. Fanola, Christian Thomas Ruff, Sabina A. Murphy, James Jin, Anil Duggal, Noe A. Babilonia, Piyamitr Sritara, Michele F. Mercuri, Pieter Willem Kamphuisen, Elliott Marshall Antman et al. · 2018 · Journal of the American Heart Association
9. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
   Gary E. Raskob, Nick van Es, Annelise E.M. Segers, Pantep Angchaisuksiri, Doyeun Oh, Zoltan Boda, Roger M. Lyons, Karina Meijer, Ivan Gudz, Jeffrey Ian Weitz et al. · 2016 · The Lancet Haematology
10. Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes
    Laurel A. Grisanti · 2018 · Frontiers in Physiology
11. Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
    Ji‐Guang Wang · 2025 · 老年心脏病学杂志：英文版
12. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
    Björck, Fredrik, Renlund, Henrik, Lip, Gregory Y. H., Wester, Per, Svensson, Peter J., Själander, Anders · 2016 · JAMA Cardiology
13. Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement
    Julia Seeger, Birgid Gonska, Christoph Rodewald, Wolfgang Rottbauer, Jochen Wöhrle · 2017 · JACC: Cardiovascular Interventions
14. Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis
    Kuo‐Li Pan, Daniel E. Singer, Bruce Ovbiagele, Yi‐Ling Wu, Mohamed Ahmed, Meng Lee · 2017 · Journal of the American Heart Association
15. 2018 Korean Guideline of Atrial Fibrillation Management
    Boyoung Joung, Jung‐Myung Lee, Ki Hong Lee, Tae‐Hoon Kim, Eue‐Keun Choi, Woo‐Hyun Lim, Ki‐Woon Kang, Jae‐Sun Uhm, Hong Euy Lim, Junbeom Park et al. · 2018 · Korean Circulation Journal
16. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
    Keith A.A. Fox, Joseph E. Lucas, Karen S. Pieper, Jean‐Pierre Bassand, A. John Camm, David Andrew Fitzmaurice, Samuel Zachary Goldhaber, Shinya Goto, Sylvia K. Haas, Werner Hacke et al. · 2017 · BMJ Open
17. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
    Danielle Clarkesmith, Helen M. Pattison, Phyo Khaing, Deirdre A. Lane · 2017 · Cochrane Database of Systematic Reviews
18. Reversal of anticoagulants: an overview of current developments
    Thomas Thiele, Kathleen Selleng, Andreas Greinacher · 2015 · Thrombosis and Haemostasis
19. Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
    Yi‐Hsin Chan, Lai‐Chu See, Hui‐Tzu Tu, Yung‐Hsin Yeh, Shang‐Hung Chang, Lung‐Sheng Wu, Hsin‐Fu Lee, Chun‐Li Wang, Chang‐Fu Kuo, Chi-Tai Kuo · 2018 · Journal of the American Heart Association
20. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
    Bianca Rocca, Keith A.A. Fox, Ramzi Ajjan, Felicita Andreotti, Colin Baigent, Jean‐Philippe Collet, Erik Lerkevang Grove, Sigrun Halvorsen, Kurt Huber, João Morais et al. · 2018 · European Heart Journal
21. Atrial Fibrillation
    Gregory F. Michaud, William G. Stevenson · 2021 · New England Journal of Medicine
22. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1
    Hans‐Christoph Diener, James Aisenberg, Jack Ansell, Dan Atar, GÜNTER E. BREITHARDT, John W. Eikelboom, Michael D. Ezekowitz, Christopher Bull Granger, Jonathan L. Halperin, Stefan Hans Hohnloser et al. · 2016 · European Heart Journal
23. National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999–2013
    James V. Freeman, Yun Wang, Joseph G. Akar, Nihar R. Desai, Harlan M. Krumholz · 2017 · Circulation
24. Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies
    Shahrzad Salmasi, Peter S Loewen, Rachel Tandun, Jason G. Andrade, Mary A. De Vera · 2020 · BMJ Open
25. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
    Andreas Zirlik, Christoph Bode · 2016 · Journal of Thrombosis and Thrombolysis
26. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis
    Yuko Nagaoki, Hiroshi Aikata, Kana Daijo, Yuji Teraoka, Fumi Shinohara, Yuki Nakamura, Masahiro Hatooka, Kei Morio, Takashi Nakahara, Tomokazu Kawaoka et al. · 2017 · Hepatology Research
27. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation
    David J. Graham, Elande Baro, Rongmei Zhang, Jiemin Liao, Michael Wernecke, Marsha E. Reichman, Mao Hu, Onyekachukwu A. Illoh, Yuqin Wei, Margie R. Goulding et al. · 2019 · The American Journal of Medicine
28. Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
    J. Beyer-Westendorf, K. Förster, Franziska Ebertz, Vera Gelbricht, T. Schreier, M. Gobelt, Franziska Michalski, Heike Endig, Kurtuluş Şahin, Luise Tittl et al. · 2015 · EP Europace
29. Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
    Yee Cheng Lau, Marco Proietti, Elisa Guiducci, Andrew D. Blann, Gregory Y.H. Lip · 2016 · Journal of the American College of Cardiology
30. Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation
    John W. Eikelboom, Daniel J. Quinlan, Jack Hirsh, Stuart J. Connolly, Jeffrey Ian Weitz · 2017 · JAMA Cardiology
31. Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
    Lane, Deirdre A., Aguinaga, Luis, Blomström-Lundqvist, Carina, Boriani, Giuseppe, Dan, Gheorge-Andrei, Hills, Mellanie True, Hylek, Elaine M., LaHaye, Stephen A., Lip, Gregory Y.H., Lobban, Trudie et al. · 2015 · Europace
32. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
    Raffaele De Caterina, Giulia Renda, Anthony Carnicelli, Francesco Nordio, Marco Trevisan, Michele F. Mercuri, Christian Thomas Ruff, Elliott Marshall Antman, Eugene Braunwald, Robert Patrick Giugliano · 2017 · Journal of the American College of Cardiology
33. Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial
    Takeshi Fuji, Ching‐Jen Wang, Satoru Fujita, Yohko Kawai, Mashio Nakamura, Tetsuya Kimura, Kei Ibusuki, Hitoshi Ushida, Kenji Abe, Shintaro Tachibana · 2014 · Thrombosis Research
34. Direct Oral Anticoagulants: A Quick Guide
    Sikorska Julia, James Uprichard · 2017 · European Cardiology Review
35. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
    Hans‐Christoph Diener, James Aisenberg, Jack Ansell, Dan Atar, GÜNTER E. BREITHARDT, John W. Eikelboom, Michael D. Ezekowitz, Christopher Bull Granger, Jonathan L. Halperin, Stefan Hans Hohnloser et al. · 2016 · European Heart Journal
36. Pathophysiology of atrial fibrillation and chronic kidney disease
    Wern Yew Ding, Dhiraj Gupta, Christopher F. Wong, Gregory Y.H. Lip · 2020 · Cardiovascular Research
37. Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation
    Franziska Ebertz, Kati Förster, Vera Gelbricht, Franziska Michalski, Christina U. Köhler, Sebastian Werth, Heike Endig, Sven Pannach, Luise Tittl, Kurtuluş Şahin et al. · 2015 · Thrombosis and Haemostasis
38. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
    Miho Kimachi, Toshi A. Furukawa, Kimihiko Kimachi, Yoshihito Goto, Shingo Fukuma, Shunichi Fukuhara · 2017 · Cochrane Database of Systematic Reviews
39. 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation
    Chern‐En Chiang, Tsu-Juey Wu, Kwo-Chang Ueng, Tze‐Fan Chao, Kuan‐Cheng Chang, Chun-Chieh Wang, Yenn‐Jiang Lin, Wei‐Hsian Yin, Jen‐Yuan Kuo, Wei‐Shiang Lin et al. · 2016 · Journal of the Formosan Medical Association
40. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
    David D. Berg, Christian Thomas Ruff, Petr Jarolı́m, Robert Patrick Giugliano, Francesco Nordio, Hans Lanz, Michele F. Mercuri, Elliott Marshall Antman, Eugene Braunwald M. D, David A. Morrow · 2019 · Circulation
41. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
    Gregory Y.H. Lip, Jean‐Philippe Collet, Raffaele De Caterina, Laurent Fauchier, Deirdre A. Lane, Torben Bjerregaard Larsen, Francisco R. Marín, João Morais, Calambur Narasimhan, Brian Olshansky et al. · 2017 · EP Europace
42. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
    James V. Freeman, Angela Y. Higgins, Yongfei Wang, Chengan Du, Daniel J. Friedman, Usama A. Daimee, Karl E. Minges, Lucy Pereira, Andrew Michael Goldsweig, Matthew J. Price et al. · 2022 · Journal of the American College of Cardiology
43. Risk of Gastrointestinal Bleeding in Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis
    Corey Miller, Alastair P. Dorreen, Myriam Martel, Thao Thanh Huynh, Alan N. Barkun · 2017 · Clinical Gastroenterology and Hepatology
44. Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs
    Freek W.A. Verheugt, Christopher Bull Granger · 2015 · The Lancet
45. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know
    Susan E. Conway, Andrew Y. Hwang, Charles D. Ponte, John G. Gums · 2016 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
46. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack
    Yongjun Wang, Ming Liu, Chuanqiang Pu · 2017 · International Journal of Stroke
47. Heart Failure as a Risk Factor for Stroke
    Woohyeun Kim, Eung Ju Kim · 2018 · Journal of Stroke
48. Inappropriate Use of Oral Anticoagulants for Patients With Atrial Fibrillation
    Masaharu Akao, Yeong‐Hwa Chun, Masahiro Esato, Mitsuru Abe, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, on behalf of the Fushimi AF Registry Investigators · 2014 · Circulation Journal
49. Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
    Hyunmee Kim, Hyeongsoo Kim, Seong-Kyung Cho, Jin‐Bae Kim, Boyoung Joung, Changsoo Kim · 2018 · Korean Circulation Journal
50. Control de la anticoagulación en pacientes con fibrilación auricular no valvular asistidos en atención primaria en España. Estudio PAULA
    Vivencio Barrios, Carlos Escobar, Luís Prieto, Genoveva Osorio, José Polo, José María Lobos, Diego Vargas, Nicolás García · 2015 · Revista Española de Cardiología
51. The Significance of Drug–Drug and Drug–Food Interactions of Oral Anticoagulation
    Pascal Vranckx, Marco Valgimigli, Hein Heidbüchel · 2018 · Arrhythmia & Electrophysiology Review
52. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
    Thomas C Marbury, Nobuko Matsushima, Shuquan Chen, Prachi K. Wickremasingha, Ling He, Victor Dishy, Karen S Brown, Dolly A. Parasrampuria · 2015 · Thrombosis and Haemostasis
53. Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
    Jens Lutz, Kerstin Jurk, Helmut Schinzel · 2017 · International Journal of Nephrology and Renovascular Disease
54. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
    Katsushige Ono, Yu‐ki Iwasaki, Masaharu Akao, Takanori Ikeda, Kuniaki Ishii, Yasuya Inden, Kengo Kusano, Yoshinori Kobayashi, Yukihiro Koretsune, Tetsuo Sasano et al. · 2022 · Circulation Journal
55. Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
    Giuseppe Boriani, Christian Thomas Ruff, Julia Kuder, Minggao Shi, Hans Lanz, Howard Rutman, Michele F. Mercuri, Elliott Marshall Antman, Eugene Braunwald M. D, Robert Patrick Giugliano · 2018 · European Heart Journal
56. Atrial fibrillation and stroke
    Sylvia E. Choi, Dimitrios Sagris, Andrew M. Hill, Gregory Y.H. Lip, Azmil H. Abdul‐Rahim · 2022 · Expert Review of Cardiovascular Therapy
57. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
    Tatjana Potpara, Charles Joseph Ferro, Gregory Y.H. Lip · 2018 · Nature Reviews Nephrology
58. Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients with Concomitant Atrial Fibrillation and Heart Failure: A Systemic Review and Meta-Analysis of Randomized Trials
    Qinmei Xiong, Yee Cheng Lau, Keitaro Senoo, Deirdre A. Lane, Kui Hong, Gregory Y.H. Lip · 2015 · European Journal of Heart Failure
59. Why do we need observational studies of everyday patients in the real-life setting?: Table 1
    Alexander Thomas Cohen, Shinya Goto, Karen Ingrid Schreiber, Christian Tobias Torp-Pedersen · 2015 · European Heart Journal Supplements
60. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
    Giulia Renda, Fabrizio Ricci, Robert Patrick Giugliano, Raffaele De Caterina · 2017 · Journal of the American College of Cardiology
61. Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry
    Martín Ruiz Ortiz, Javier Muñiz, P Rana Miguez, Inmaculada Roldán, Francisco R. Marín, María Asunción Esteve‐Pastor, Angel R. Cequier, Manuel Martínez‐Sellés, Vicente Bertoméu, Manuel P. Anguita et al. · 2017 · EP Europace
62. Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants
    A. John Camm, Keith A.A. Fox · 2018 · Open Heart
63. Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
    So‐Ryoung Lee, Hyun‐Jung Lee, Eue‐Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Gregory Y.H. Lip · 2019 · Journal of the American College of Cardiology
64. Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study
    Saket Sanghai, Chi Hang Wong, Ziyue Wang, Pia H. Clive, Wenisa Tran, Molly E. Waring, Robert Joel Goldberg, Robert Hayward, Jane S. Saczynski, David D. McManus · 2020 · Journal of the American Heart Association
65. Edoxaban: a focused review of its clinical pharmacology
    Gregory Y.H. Lip, Giancarlo Agnelli · 2014 · European Heart Journal
66. Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients ― Fushimi AF Registry ―
    Yugo Yamashita, Ryuji Uozumi, Yasuhiro Hamatani, Masahiro Esato, Yeong‐Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe et al. · 2017 · Circulation Journal
67. Early start of DOAC after ischemic stroke
    David Julian Seiffge, Christopher Traenka, Alexandros A. Polymeris, Lisa Hert, Nils Peters, Philippe A. Lyrer, Stefan T. Engelter, Leo Hermann Bonati, Gian Marco De Marchis · 2016 · Neurology
68. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
    Stefano Ballestri, Elisa Romagnoli, Dimitriy Arioli, Valeria Coluccio, Alessandra Marrazzo, Afroditi Athanasiou, Maria Di Girolamo, Cinzia Cappi, Marco Marietta, Mariano Capitelli · 2022 · Advances in Therapy
69. Drug–Drug Interactions with Direct Oral Anticoagulants
    Kathrin Isabelle Foerster, Simon A. Hermann, Gerd Mikus, Walter E. Haefeli · 2020 · Clinical Pharmacokinetics
70. NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis
    Tim Hicks, Fiona J. Stewart, Anne Eisinga · 2016 · Open Heart
71. Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1
    Tobias Petzold, Manuela Thienel, Lisa Dannenberg, Philipp Mourikis, Carolin Helten, Aysel Ayhan, René M’Pembele, Alina Achilles, Kajetan Trojovky, Daniel Konsek et al. · 2019 · Circulation Research
72. Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation
    Dae Hyun Kim, Ajinkya M Pawar, Joshua J. Gagne, Lily Gui Bessette, Hemin Lee, Robert J. Glynn, Sebastian Schneeweiß · 2021 · Annals of Internal Medicine
73. Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
    Yi‐Hsin Chan, Hsin‐Fu Lee, Lai‐Chu See, Hui‐Tzu Tu, Tze‐Fan Chao, Yung‐Hsin Yeh, Lung‐Sheng Wu, Chi-Tai Kuo, Shang‐Hung Chang, Gregory Y.H. Lip · 2019 · CHEST Journal
74. Antithrombotic Agents
    Noel Chan, Jeffrey Ian Weitz · 2019 · Circulation Research
75. Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
    Min Soo Cho, Do‐Yoon Kang, Jung‐Min Ahn, Sung-Cheol Yun, Yong‐Seog Oh, Chang Hoon Lee, Eue‐Keun Choi, Ji Hyun Lee, Chang Hee Kwon, Gyung‐Min Park et al. · 2024 · New England Journal of Medicine
76. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials
    George Ntaios, Vasileios Papavasileiou, Hans-Chris Diener, Konstantinos P. Makaritsis, Patrik Michel · 2017 · International Journal of Stroke
77. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial
    Chris Wilkinson, Jianhua Wu, Samuel D. Searle, Oliver M. Todd, Marlous Hall, Vijay Kunadian, Andrew Paul Clegg, Kenneth J. Rockwood, Chris P Gale · 2020 · BMC Medicine
78. Atrial Fibrillation and Ischemic Stroke: A Clinical Review
    Ibrahim Migdady, Andrew Russman, Andrew Blake Buletko · 2021 · Seminars in Neurology
79. Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study
    PASSMAN, ROD, LEONG‐SIT, PETER, ANDREI, ADIN‐CRISTIAN, HUSKIN, ANNA, TOMSON, TODD T., BERNSTEIN, RICHARD, ELLIS, ETHAN, WAKS, JONATHAN W., ZIMETBAUM, PETER · 2016 · Journal of Cardiovascular Electrophysiology
80. Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery
    Etem Caliskan, Ayhan Sahin, Murat Yılmaz, Burkhardt Seifert, Ricarda Hinzpeter, Hatem Alkadhi, James L. Cox, Tomáš Holubec, Diana Reser, Volkmar Falk et al. · 2017 · EP Europace
81. Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
    Amitava Banerjee, Valerio Benedetto, Phillip Gichuru, Jane Burnell, Sotiris Antoniou, RICHARD JOHN SCHILLING, William David Strain, Ronan P. Ryan, Caroline Leigh Watkins, Tom P Marshall et al. · 2019 · Heart
82. A practical approach to the management of cerebral amyloid angiopathy
    Mariel G. Kozberg, Valentina Perosa, M. Edip Gurol, Susanne J. van Veluw · 2020 · International Journal of Stroke
83. Drug–drug interactions with warfarin: A systematic review and meta‐analysis
    Mei Wang, Dena Zeraatkar, Michael Obeda, Munil Lee, Michael Cristian Garcia, Laura Nguyen, Arnav Agarwal, Farah Al‐Shalabi, Harsukh Benipal, Afreen Ahmad et al. · 2021 · British Journal of Clinical Pharmacology
84. 2024 Clinical practice guidelines for Stable coronary artery disease
    О. Л. Барбараш, Yu. A. Karpov, A. V. Panov, Renat S. Akchurin, Bagrat G. Alekyan, Mikhail N. Alekhin, D. M. Aronov, GOHAR HARUTYUNYAN, Yu. N. Belenkov, Sergey Anatol'evich Boytsov et al. · 2024 · Russian Journal of Cardiology
85. Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation
    Tze‐Fan Chao, Kang-Ling Wang, Chia-Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Fa‐Po Chung, Jo‐Nan Liao et al. · 2015 · Journal of the American College of Cardiology
86. Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy
    Brandon William Calenda, Valentı́n Fuster, Jonathan L. Halperin, Christopher Bull Granger · 2016 · Nature Reviews Cardiology
87. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants
    Rahul Aggarwal, Christian Thomas Ruff, Saverio Virdone, Sylvie Perreault, Ajay K. Kakkar, Michael G. Palazzolo, Marc Dorais, Gloria Kayani, Daniel E. Singer, Eric Alexander Secemsky et al. · 2023 · Circulation
88. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding
    Wayne A. Ray, Cecilia P. Chung, Katherine T. Murray, Walter E. Smalley, James R. Daugherty, William D. Dupont, C. Michael Stein · 2016 · Gastroenterology
89. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events
    Natalia S. Rost, Robert Patrick Giugliano, Christian Thomas Ruff, Sabina A. Murphy, Andrea E. Crompton, Andrew David Norden, Scott B. Silverman, Aneesh B. Singhal, José Carlos Nicolau, Bhupathi SomaRaju et al. · 2016 · Stroke
90. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
    Renato D. Lópes, Patrícia O. Guimarães, Brad J. Kolls, DANIEL M. WOJDYLA, Cheryl Bushnell, Michael Hanna, J. Donald Easton, Laine Elliott Thomas, Lars C. Wallentin, Sana M. Al‐Khatib et al. · 2017 · Blood
91. Deep Venous Thrombosis
    Mark F. Olaf, Robert R. Cooney · 2017 · Emergency Medicine Clinics of North America
92. Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
    Chris G Cameron, Doug Coyle, Trevor A. Richter, Shannon Kelly, Kasandra Gauthier, Sabine Steiner, Marc Carrier, Kathryn Coyle, Annie Bai, Kristen Moulton et al. · 2014 · BMJ Open
93. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin
    Matthew J. Price, Vivek Yerrapu Reddy, Miguel Valderrábano, Jonathan L. Halperin, Douglas N Gibson, Nicole T. Gordon, Kenneth Christopher Huber, David R. Holmes · 2015 · JACC: Cardiovascular Interventions
94. Edoxaban in Asian Patients With Atrial Fibrillation
    So‐Ryoung Lee, Eue‐Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Seil Oh, Gregory Y.H. Lip · 2018 · Journal of the American College of Cardiology
95. Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
    Haiyan Xu, Christian Thomas Ruff, Robert Patrick Giugliano, Sabina A. Murphy, Francesco Nordio, Indravadan J. Patel, Minggao Shi, Michele F. Mercuri, Elliott Marshall Antman, Eugene Braunwald · 2016 · Journal of the American Heart Association
96. Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
    Stefan Hans Hohnloser, Marat Fudim, John Hunter Alexander, DANIEL M. WOJDYLA, Justin Adrian Ezekowitz, Michael Hanna, Dan Atar, Ziad Hijazi, Maria Cecilia Bahit, Sana M. Al‐Khatib et al. · 2019 · Circulation
97. Trends in anticoagulant prescribing: a review of local policies in English primary care
    Katherine H. Ho, Maria van Hove, Gillian C. Leng · 2020 · BMC Health Services Research
98. Practical Management of Anticoagulation in Patients With Atrial Fibrillation
    Richard J. Kovacs, Greg C. Flaker, Sherry J. Saxonhouse, John U. Doherty, Kim K. Birtcher, Adam C. Cuker, Bruce L. Davidson, Robert Patrick Giugliano, Christopher Bull Granger, Amir K. Jaffer et al. · 2015 · Journal of the American College of Cardiology
99. Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation – An ENGAGE AF-TIMI 48 Subanalysis –
    Takeshi Yamashita, Yukihiro Koretsune, Yuejin Yang, Shih‐Ann Chen, Namsik Chung, Yuichi J. Shimada, Tetsuya Kimura, Koichi Miyazaki, Kenji Abe, Michele F. Mercuri et al. · 2016 · Circulation Journal
100. STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management
     Pierre R. Tibi, Robert Scott McClure, Jiapeng Huang, Robert A. Baker, David Fitzgerald, C. David Mazer, Marc E. Stone, Danny Chu, Alfred H. Stammers, Tim Dickinson et al. · 2021 · Journal of Cardiothoracic and Vascular Anesthesia